Tempo Wealth’s Elevance Health ELV Stock Holding History

Tempo Wealth’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Sell	1,088 -32	-3%	-$11.9K	0.06%	165
2026 Q1	$328K	Buy	1,120 +6	+0.5%	+$1.97K	0.06%	172
2025 Q4	$391K	Buy	+1,114	New	+$376K	0.07%	154

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tempo Wealth's ELV Position: Q2 2026 in Review

Tempo Wealth reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $11.9K and leaving 1,088 shares worth $421K. The position accounts for 0.06% of the portfolio, ranked #165.

Tempo Wealth first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Tempo Wealth held 1,088 shares of Elevance Health worth $421K as of Q2 2026.
Tempo Wealth sold 32 Elevance Health shares in Q2 2026, an estimated $11.9K.
Elevance Health made up 0.06% of Tempo Wealth's portfolio in Q2 2026, its #165 holding.
Tempo Wealth first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Tempo Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.